The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients

Oz, M. D., Ozdemir, F., Tok, K. C., Dural, E., Kir, Y., Ulusoy, M., Gumustas, M., Baskak, B., & Suzen, H. S. (2023). The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients. Expert Opinion on Drug Metabolism & Toxicology, 19(5), 319-327. https://doi.org/10.1080/17425255.2023.2221849

Oz MD, Ozdemir F, Tok KC, Dural E, Kir Y, Ulusoy M, et al. The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients. Expert Opinion on Drug Metabolism & Toxicology. 2023;19(5):319-327. doi:10.1080/17425255.2023.2221849

Oz, Merve Demirbugen, Fezile Ozdemir, Kenan Can Tok, Emrah Dural, Yagmur Kir, Muge Ulusoy, Mehmet Gumustas, Bora Baskak, and H. Sinan Suzen. 2023. “The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients.” Expert Opinion on Drug Metabolism & Toxicology 19 (5): 319-327. https://doi.org/10.1080/17425255.2023.2221849.

Oz, Merve Demirbugen, et al. “The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients.” Expert Opinion on Drug Metabolism & Toxicology, vol. 19, no. 5, 2023, pp. 319-327. https://doi.org/10.1080/17425255.2023.2221849.

Oz, M.D., Ozdemir, F., Tok, K.C., Dural, E., Kir, Y., Ulusoy, M., Gumustas, M., Baskak, B. and Suzen, H.S. (2023) ‘The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients’, Expert Opinion on Drug Metabolism & Toxicology, 19(5), pp. 319-327. doi:10.1080/17425255.2023.2221849.